Dr. Reddy's Laboratories Files 6-K Report

Ticker: RDY · Form: 6-K · Filed: Oct 31, 2025 · CIK: 1135951

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer, pharmaceuticals

TL;DR

DRL filed a 6-K, standard foreign issuer report. Nothing major disclosed.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 31, 2025, reporting for the period ending October 24, 2025. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer. This filing is a routine report for foreign private issuers.

Why It Matters

This filing provides an update on Dr. Reddy's Laboratories' regulatory reporting status as a foreign private issuer, which is important for investors tracking the company's compliance and disclosures.

Risk Assessment

Risk Level: low — The filing is a routine report for a foreign private issuer and does not contain any new material financial information or significant corporate events.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer either is required to make public pursuant to the laws of its home country, or is required to publish or is permitted to publish.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is October 31, 2025.

What period does this Form 6-K report cover?

This Form 6-K reports for the period ended October 24, 2025.

Where is Dr. Reddy's Laboratories Ltd. headquartered?

Dr. Reddy's Laboratories Ltd. is headquartered in Hyderabad, Telangana, India.

What is the Standard Industrial Classification code for Dr. Reddy's Laboratories Ltd.?

The Standard Industrial Classification code for Dr. Reddy's Laboratories Ltd. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2025-10-30 20:45:23

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: October 24, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing